Charles Schwab’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.05M Buy
2,541,898
+98,838
+4% +$119K ﹤0.01% 2534
2025
Q1
$2.64M Buy
2,443,060
+110,411
+5% +$119K ﹤0.01% 2525
2024
Q4
$4.08M Sell
2,332,649
-112,434
-5% -$197K ﹤0.01% 2427
2024
Q3
$4.72M Buy
2,445,083
+1,597,728
+189% +$3.08M ﹤0.01% 2401
2024
Q2
$1.5M Buy
847,355
+735,771
+659% +$1.3M ﹤0.01% 2788
2024
Q1
$302K Buy
111,584
+80,392
+258% +$218K ﹤0.01% 3174
2023
Q4
$68.9K Hold
31,192
﹤0.01% 3371
2023
Q3
$90.5K Hold
31,192
﹤0.01% 3364
2023
Q2
$60.2K Hold
31,192
﹤0.01% 3394
2023
Q1
$60.8K Buy
+31,192
New +$60.8K ﹤0.01% 3316
2022
Q4
Sell
-27,127
Closed -$30K 3555
2022
Q3
$30K Hold
27,127
﹤0.01% 3434
2022
Q2
$44K Sell
27,127
-170,026
-86% -$276K ﹤0.01% 3407
2022
Q1
$708K Buy
197,153
+5,688
+3% +$20.4K ﹤0.01% 2985
2021
Q4
$751K Hold
191,465
﹤0.01% 3018
2021
Q3
$1.26M Buy
191,465
+5,362
+3% +$35.3K ﹤0.01% 2794
2021
Q2
$1.15M Buy
186,103
+455
+0.2% +$2.8K ﹤0.01% 2879
2021
Q1
$840K Buy
185,648
+4,266
+2% +$19.3K ﹤0.01% 2908
2020
Q4
$1.09M Buy
181,382
+14,652
+9% +$88K ﹤0.01% 2745
2020
Q3
$1.24M Sell
166,730
-5,693
-3% -$42.3K ﹤0.01% 2624
2020
Q2
$692K Buy
172,423
+6,091
+4% +$24.4K ﹤0.01% 2731
2020
Q1
$423K Sell
166,332
-411
-0.2% -$1.05K ﹤0.01% 2771
2019
Q4
$581K Hold
166,743
﹤0.01% 2770
2019
Q3
$773K Buy
166,743
+2,454
+1% +$11.4K ﹤0.01% 2639
2019
Q2
$2.03M Buy
164,289
+78,104
+91% +$963K ﹤0.01% 2367
2019
Q1
$1.15M Buy
86,185
+12,966
+18% +$172K ﹤0.01% 2518
2018
Q4
$632K Buy
73,219
+13,419
+22% +$116K ﹤0.01% 2682
2018
Q3
$448K Buy
59,800
+5,100
+9% +$38.2K ﹤0.01% 2877
2018
Q2
$327K Sell
54,700
-17,100
-24% -$102K ﹤0.01% 2929
2018
Q1
$420K Hold
71,800
﹤0.01% 2775
2017
Q4
$423K Buy
71,800
+15,800
+28% +$93.1K ﹤0.01% 2769
2017
Q3
$283K Sell
56,000
-8,155
-13% -$41.2K ﹤0.01% 2896
2017
Q2
$260K Sell
64,155
-11,580
-15% -$46.9K ﹤0.01% 2921
2017
Q1
$431K Sell
75,735
-24,150
-24% -$137K ﹤0.01% 2694
2016
Q4
$728K Buy
99,885
+5,236
+6% +$38.2K ﹤0.01% 2531
2016
Q3
$759K Buy
94,649
+4,372
+5% +$35.1K ﹤0.01% 2474
2016
Q2
$816K Buy
90,277
+1,344
+2% +$12.1K ﹤0.01% 2410
2016
Q1
$718K Buy
88,933
+1,632
+2% +$13.2K ﹤0.01% 2455
2015
Q4
$944K Buy
87,301
+2,080
+2% +$22.5K ﹤0.01% 2414
2015
Q3
$692K Sell
85,221
-1,215
-1% -$9.87K ﹤0.01% 2503
2015
Q2
$2.09M Buy
86,436
+5,831
+7% +$141K ﹤0.01% 2069
2015
Q1
$3.39M Buy
80,605
+3,757
+5% +$158K ﹤0.01% 1757
2014
Q4
$2.59M Buy
76,848
+2,681
+4% +$90.5K ﹤0.01% 1859
2014
Q3
$1.82M Buy
74,167
+1,636
+2% +$40.1K ﹤0.01% 2012
2014
Q2
$2.13M Sell
72,531
-214
-0.3% -$6.29K ﹤0.01% 1955
2014
Q1
$3.21M Buy
72,745
+1,917
+3% +$84.5K 0.01% 1663
2013
Q4
$2.72M Buy
70,828
+6,594
+10% +$253K 0.01% 1713
2013
Q3
$1.42M Buy
64,234
+4,425
+7% +$97.5K ﹤0.01% 2033
2013
Q2
$1.02M Buy
+59,809
New +$1.02M ﹤0.01% 2152